Holen Sie sich die Stockscreener-App
24.67
8.63%
-2.33
Handel nachbörslich:
24.50
-0.17
-0.69%
Greenwich Lifesciences Inc Aktie (GLSI) Neueste Nachrichten
Greenwich LifeSciences reports 33% rise in trial screening rate By Investing.com - Investing.com Canada
Greenwich LifeSciences reports 33% rise in trial screening rate - Investing.com
Greenwich LifeSciences accelerates patient screening in FLAMINGO-01 clinical trial - Traders Union
Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01 - GlobeNewswire
US Stocks Recap: Is Greenwich LifeSciences Inc undervalued by DCF analysisTrade Exit Summary & AI Optimized Trading Strategy Guides - baoquankhu1.vn
GLSI Should I Buy - Intellectia AI
Aug Sentiment: Can Greenwich LifeSciences Inc expand into new marketsOptions Play & Long-Term Safe Investment Ideas - baoquankhu1.vn
GLSI Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Understanding Momentum Shifts in (GLSI) - Stock Traders Daily
Greenwich LifeSciences abstracts accepted at AACR 2026 meeting By Investing.com - Investing.com Australia
Greenwich LifeSciences abstracts accepted at AACR 2026 meeting - Investing.com Nigeria
Rally Mode: Is BTCM a cyclical or defensive stockWall Street Watch & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Greenwich lands 2 AACR 2026 slots, first with FLAMINGO-01 Steering Committee - Stock Titan
GLSI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Analysis Recap: Is SPRY stock showing strong momentumQuarterly Market Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Short Interest Down 14.7% in January - MarketBeat
How interest rate cuts could boost Greenwich LifeSciences Inc. stockJuly 2025 Macro Moves & Consistent Return Investment Signals - mfd.ru
GLSI PE Ratio & Valuation, Is GLSI Overvalued - Intellectia AI
Avoiding Lag: Real-Time Signals in (GLSI) Movement - Stock Traders Daily
How buybacks impact Greenwich LifeSciences Inc. stock valueWall Street Watch & AI Powered Market Entry Ideas - mfd.ru
Aug Update: Will Greenwich LifeSciences Inc stock benefit from M A2025 Winners & Losers & Community Consensus Trade Signals - baoquankhu1.vn
Is Greenwich LifeSciences Inc. stock trending bullishRate Hike & Smart Money Movement Tracker - mfd.ru
Analyst Upgrade: Is Lavoro Limiteds growth already priced inJuly 2025 Highlights & Low Risk Growth Stock Ideas - baoquankhu1.vn
HC Wainwright Issues Positive Forecast for GLSI Earnings - MarketBeat
Valuation Update: Can Greenwich LifeSciences Inc expand into new marketsJuly 2025 Momentum & Weekly Momentum Stock Picks - baoquankhu1.vn
Greenwich LifeSciences (NASDAQ:GLSI) Stock Price Down 6.7% – Here’s What Happened - Defense World
Greenwich LifeSciences: Strengthened Liquidity and Robust GP2 Data Support Reiterated Buy and $50 Target - TipRanks
Discipline and Rules-Based Execution in GLSI Response - Stock Traders Daily
Patel, Greenwich Lifesciences CEO, buys $63k in GLSI stock By Investing.com - Investing.com Nigeria
Will Greenwich LifeSciences Inc. benefit from current market trendsTrade Signal Summary & Free Real-Time Volume Trigger Notifications - mfd.ru
Greenwich LifeSciences reports $12.5 million cash balance - Investing.com
Greenwich LifeSciences reports $12.5 million cash balance By Investing.com - Investing.com Nigeria
Greenwich LifeSciences provides update on Flamingo-01 cash burn rate and financing strategy - marketscreener.com
Greenwich LifeSciences, Inc. Reports Positive Financial Updates and Progress on FLAMINGO-01 Phase III Trial - Quiver Quantitative
Greenwich Lifesciences Provides Update On Flamingo-01 Cash Burn Rate And Financing Strategy - TradingView
Biotech Greenwich LifeSciences raises $7M in 3 weeks for breast cancer trial - Stock Titan
FDA Approval Boosts Greenwich LifeSciences Stock Sharply - timothysykes.com
Treasury Yields: Will Greenwich LifeSciences Inc benefit from current market trendsMarket Volume Report & Low Risk Entry Point Tips - baoquankhu1.vn
Greenwich: GP2 Vaccine MilestoneWhat FDA Manufacturing Approval Means For Investors - Seeking Alpha
Insiders of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) must be frustrated after market cap dropped US$50m since recent purchases - Yahoo Finance
Behavioral Patterns of GLSI and Institutional Flows - Stock Traders Daily
FDA approves commercial GP2 lot for Greenwich’s breast cancer trial By Investing.com - Investing.com Canada
Why Did Greenwich Lifesciences Stock Soar Pre-Market Today? - Menafn.com
Why Did Greenwich LifeSciences Stock Soar Pre-Market Today? - Asianet Newsable
GLSI Stock Surges Pre-Market On Clearing FDA Manufacturing Step For Its Breast Cancer Trial - Stocktwits
Greenwich LifeSciences stock soars after FDA approves commercial GP2 in trial - Investing.com Canada
Greenwich gets FDA nod for commercially made product candidate - Seeking Alpha
Greenwich LifeSciences surges as FDA clears supplies for breast cancer trial - TradingView
Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01 - The Manila Times
FDA approves first GP2 batch for breast cancer trial, 200,000 doses - Stock Titan
Head to Head Contrast: Greenwich LifeSciences (NASDAQ:GLSI) & Vertex Pharmaceuticals (NASDAQ:VRTX) - Defense World
Insider Buying: Greenwich LifeSciences (NASDAQ:GLSI) CEO Acquires 1,800 Shares of Stock - MarketBeat
Greenwich LifeSciences CEO Patel buys $53,694 in GLSI stock By Investing.com - Investing.com Canada
Greenwich LifeSciences stockholders reelect board and auditor - MSN
The $69B Precision Pivot: Why Biomarker Platforms are Igniting a New Oncology Gold Rush - Baystreet.ca
Insider Buying: Greenwich LifeSciences (NASDAQ:GLSI) CEO Purchases 2,900 Shares of Stock - MarketBeat
Greenwich LifeSciences CEO Patel buys $79,866 in GLSI stock By Investing.com - Investing.com South Africa
Greenwich LifeSciences CEO Patel buys $79,866 in GLSI stock - Investing.com
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):